@article{6620,
  keywords = {Drug Therapy, Combination, Follow-Up Studies, Humans, Leprostatic Agents, leprosy, Leprosy, Borderline, Leprosy, lepromatous, Mycobacterium leprae, Philippines, Recurrence, Risk Factors, Treatment Failure, World Health Organization},
  author = {Gelber R and Balagon VF and Cellona RV},
  title = {The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.},
  abstract = {<p>A group of multibacillary patients is clearly at high risk for relapse following 2-yr WHO-MDT. Relapse is largely confined to BL or LL patients with a high BI initially, and occurs long after the discontinuation of therapy. This important group of patients at risk for treatment failure presents several important issues: the need to identify those at risk and the operational requirements needed for their long term follow-up. Also, this group of patients might well benefit from an alternative antimicrobial regimen from the outset, as well as upon relapse.</p>},
  year = {2004},
  journal = {International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association},
  volume = {72},
  pages = {493-500},
  month = {2004 Dec},
  issn = {0148-916X},
  url = {http://ila.ilsl.br/pdfs/v72n4a13.pdf},
  doi = {10.1489/1544-581X(2004)72<493:TRRIML>2.0.CO;2},
  language = {eng},
}